Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9050
+0.0450 (2.42%)
NASDAQ · Last Trade: Apr 30th, 1:19 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors